Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05098873
Other study ID # RIPH 2021-02
Secondary ID 2021-A01118-33
Status Completed
Phase
First received
Last updated
Start date February 1, 2022
Est. completion date December 15, 2023

Study information

Verified date March 2024
Source Centre Psychothérapique de Nancy
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The research focuses on "High Potential" (HP) in adolescence, in a link with the professional practice of the investigators. Furthermore, supported by scientific literature and professional clinical practice, this research is interested in school boredom, regularly expressed by the consulting adolescents, in its relation with a depressive syndrome. The objective of the research is to know if school boredom is a precursor of a depressive episode in high school students with HP compared to high school students without HP.


Description:

The investigators are questioning the meaning of school boredom experienced by adolescents with HP and its link with a depressive syndrome. The investigators will use clinical interviews, rating scales for a quantitative measure and projective tests for a psychodynamic study. The responses of adolescents with HP will be compared to those of adolescents without HP.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 15, 2023
Est. primary completion date December 15, 2023
Accepts healthy volunteers No
Gender All
Age group 14 Years to 17 Years
Eligibility Inclusion Criteria: - Adolescents coming for consultation in a medical-psychological center of Sponsor - Adolescents aged 14 to 16 years and 11 months. - Adolescents expressing a psychological malaise and/or an anxiety disorder at the time of the consultation request - Adolescents who were informed about the study, received the information note about it and did not object to participating - At least one parent or guardian who was informed of the study, received the study information sheet, and did not object to the child's participation - Adolescents affiliated or entitled to a social security plan Exclusion Criteria: - Adolescents who do not understand the French language well enough to complete the questionnaires. - Adolescents with a clear diagnosis of psychiatric pathology (e.g. schizophrenia) - Adolescents with an IQ = 80 because the level of intellectual efficiency would be too fragile and too far from the expectations of our research.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
psychodynamic
intervention with adolescents through the presentation of questions to be completed

Locations

Country Name City State
France Centre Psychothérapique de Nancy - CMP Adolescents Lunéville Lunéville

Sponsors (1)

Lead Sponsor Collaborator
Centre Psychothérapique de Nancy

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Wechsler Intelligence Scale for Children Intelligence test that measures a child's intellectual ability and 5 cognitive domains that impact performance. Month 2 or 3
Primary Échelle de Disposition à l'Ennui (French Title) Boredom scale It is the French adaptation of the Boredom Proneness Scale Month 1 or 2
Primary Rorschach test Projective test Month 3
Primary Thematic Apperception Test Projective test Month 3
Secondary Multidimensional Anxiety Scale for Children Anxiety scale Month 1 or 2
Secondary Children Depression Inventory Depression scale Month 1 or 2
Secondary Self-Perception Profile for Adolescents Self-esteem scale This self-report scale taps how adolescents assess their "competence" or "adequacy" in different areas of their life, and how they evaluate their overall self-worth as a person. Month 1 or 2
See also
  Status Clinical Trial Phase
Completed NCT01699295 - Physical Activity and Academic Achievement Across the Curriculum (A+PAAC) N/A
Completed NCT02179450 - Cognitive Function and Emotional Possessing in Bilateral Facial Palsy N/A